Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]
Mevion Medical closes $150m funding round
Mevion Medical Systems said today it closed a $150 million financing round with funds slated to support the company’s proton therapy devices and to expand manufacturing. The round was led by YuanMing Capital and joined by Henan Maisheng Medical Technology and existing investors including HOPU Investments and China Everbright Limited, the Littleton, Mass.-based company said. […]
Mevion touts first use of S250i proton therapy system
Mevion Medical Systems today announced the launch of its Mevion S250i proton therapy system, touting that the first patient in the world had been treated with the system. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. The […]
Mevion wins FDA 510(k) for S250i proton therapy system
Mevion Medical Systems said yesterday it won FDA 510(k) clearance for its Mevion S250i proton therapy system featuring pencil beam scanning technology, and touted that the first unit was installed at MedStar Georgetown University Hospital in Washington D.C. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for […]
7 medtech stories we missed this week: Nov. 17, 2017
From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]
Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. “We focused […]
7 medtech stories we missed this week: May 5, 2017
From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Biomerics opening new corporate HQ Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The […]
Mevion touts new proton therapy tech
Mevion Medical Systems announced its latest development in proton therapy, touting improvements that could allow its Hyperscan system to treat tumors other proton therapy systems cannot. The announcement was made at the 58th annual ASTRO meeting this week in Boston. CEO Joseph Jachinowski told MassDevice.com that the Littleton, Mass.-based company’s Hyperscan system is now integrated with the Adaptive […]
After shelving $69m IPO, Mevion Medical lands $200m, launches China JV
Mevion Medical Systems, which last week shelved plans for a $69 million initial public offering, this week said it raised $200 million from a syndicate of Chinese and U.S. investors and launched a joint venture in the People’s Republic. President & CEO Joe Jachinowski told MassDevice.com today that Mevion, which makes the S250 proton therapy system, […]
Mevion pulls plug on $69m IPO
Mevion Medical withdrew plans for the $69 million initial public offering it registered for last fall, according to an SEC filing published last week. The company produces single-room-proton therapy systems, a smaller, cheaper radiation therapy system for targeting cancerous tumors. The Littleton, Mass.-based company said it decided not to pursue the offering because “the terms currently […]
MassDevice Network
@MassDevice
LinkedIn
YouTube